General information
All starting materials were commercially available and were used without further purification.
Melting points were determined on a Büchi B-540 capillary melting point apparatus and uncorrected. Optical ratations were determined by using a AUTOPOL V Polarimeter. 1 H NMR and 13 C NMR spectra were recorded on a Varian-400 MHz spectrometer at 400 and 100 MHz for solution in CDCl 3 with tetramethylsilane (TMS, δ= 0) as an internal standard. The chemical shift (d) were reported in ppm and coupling constants J were expressed in Hertz. Less solution mass spectra were obtained with a Trace DSQ mass spectrometer in ESI mode. High resolution mass spectra were acquired with an Agilent 6210 TOF mass spectrometer. The enantiomeric excesses of target molecules were obtained with chiral-phase HPLC analysis, which using Agilent 1200 HPLC (Chromatographic Column: Daicel Chiralcel AD-RH or OD-RH and eluting with acetonitrile /H 2 O) with DAD UV detector. The γ-substituted allenoates 1 were prepared following the literature procedure. 1 The succinimides 2 were prepared following the literature procedure. A solution of 4-phenyl-2, 3-butadienoate 1a (0.11 g, 0.6 mmol) and 3-methylene-1-phenylpyrrolidine-2,5-dione 2a (0.09 g, 0.5 mmol) and PPh 3 (13.1 mg, 0.05 mmol) in CHCl 3 (5.0 mL) was stirred at room temperature for 12h. The solvent was removed under reduced pressure and the residue was purified by column chromatography to give ()-3a (0.13 g, 70%) as a colorless oil.
• 0, 173.7, 163.7, 163.2, 160.7, 142.3, 136.5, 135.0, 129.2(2C), 128.3, 128.0(3C), 127.7, 116.2, 115.9, 60.9, 58.6, 55.4, 44.4, 39.5, 14.4 
Ethyl 2-(4-bromophenyl)-1,3-dioxo-9-phenyl-2-azaspiro[4.4]non-7-ene-7-carboxylate (()-3f):
217mg, 96% yield; white solid; m. 1, 163.7, 148.5, 142.3, 136.3, 135.2, 132.9, 132.0, 130.0, 129.4(2C), 128.7, 128.2(2C), 123.3, 121.6, 61.1, 58.8, 55.8, 44.5, 39.8, 14.6 4, 174.2, 163.8, 159.4, 142.5, 136.6, 135.1, 129.2(2C), 128.3, 14 128.1(2C), 127.5(2C), 124.5, 114.5(2C), 61.0, 58.9, 55.6, 55.6, 55.5, 44.6, 14.5; MS (ESI) 8, 173.4, 163.8, 142.4, 136.5, 135.1, 134.7, 132.8, 130.1, 129.3(2C), 128.8, 128.5, 128.1(2C), 126.5, 124.4, 61.1, 58.7, 55.6, 44.6,39.7, 14.5 
Ethyl 1,3-dioxo-9-phenyl-2-(p-tolyl)-2-azaspiro[4.4]non-7-ene-7-carboxylate ((
)
